Spondyloarthropathies
From the Journals
Low BMD and spinal syndesmophytes predict radiographic progression in axSpA
Low BMD and the presence of existing spinal syndesmophytes predict the formation of new spinal bony growths and radiographic progression in axial...
From the Journals
No evidence of subclinical axial involvement seen in skin psoriasis
Patients with longstanding psoriasis without peripheral or axial inflammation are unlikely to have subclinical involvement of the sacroiliac joint...
From the Journals
Arthritis prevalent in older adults with any degree of depression
Older patients with depressive symptoms should be screened for arthritis-related pain.
From the Journals
Repeat MRI not useful in suspected axial spondyloarthritis
Male gender and HLA-B27 positivity were found to be important predictors of a positive MRI.
From the Journals
Infliximab biosimilar only moderately less expensive in Medicare Part D
Without biosimilar gap discounts in 2017, beneficiaries would have paid nearly $1,700 more in projected out-of-pocket costs for infliximab-dyyb...
Latest News
Diclofenac’s cardiovascular risk confirmed in novel Nordic study
For the world’s most commonly used NSAID, the risk is real, according to 2 decades of Danish health data.
From the Journals
AS inflammatory back pain criteria fall short in PsA
The presence or absence of back pain in patients with axial radiologic involvement did not affect prognosis, suggesting the value of considering...
Conference Coverage
Biosimilar switch accepted by most rheumatic disease patients
LIVERPOOL, ENGLAND – With health systems increasingly favoring biosimilars to biologics, the question is, are patients happy to make the switch?...
Conference Coverage
Ankylosing spondylitis progression slowed when NSAIDs added to TNFi
Latest News
Methotrexate proves largely ineffective for maintaining peripheral SpA remission
AMSTERDAM – More than half of patients who started golimumab (Simponi) within 12 weeks of symptom onset had complete remission of SpA.